214 related articles for article (PubMed ID: 33971279)
1. Inhibition of mTOR by rapamycin does not improve hypoxic pulmonary hypertension-induced right heart failure in old mice.
McNair BD; Schlatter JA; Cook RF; Yusifova M; Bruns DR
Exp Gerontol; 2021 Aug; 151():111395. PubMed ID: 33971279
[TBL] [Abstract][Full Text] [Related]
2. Metformin protects against pulmonary hypertension-induced right ventricular dysfunction in an age- and sex-specific manner independent of cardiac AMPK.
McNair BD; Polson SM; Shorthill SK; Yusifov A; Walker LA; Weiser-Evans MCM; Kovacs EJ; Bruns DR
Am J Physiol Heart Circ Physiol; 2023 Aug; 325(2):H278-H292. PubMed ID: 37389952
[TBL] [Abstract][Full Text] [Related]
3. Pharmacological Inhibition of mTOR Kinase Reverses Right Ventricle Remodeling and Improves Right Ventricle Structure and Function in Rats.
Pena A; Kobir A; Goncharov D; Goda A; Kudryashova TV; Ray A; Vanderpool R; Baust J; Chang B; Mora AL; Gorcsan J; Goncharova EA
Am J Respir Cell Mol Biol; 2017 Nov; 57(5):615-625. PubMed ID: 28679058
[TBL] [Abstract][Full Text] [Related]
4. Altered mTOR and Beclin-1 mediated autophagic activation during right ventricular remodeling in monocrotaline-induced pulmonary hypertension.
Deng Y; Wu W; Guo S; Chen Y; Liu C; Gao X; Wei B
Respir Res; 2017 Mar; 18(1):53. PubMed ID: 28340591
[TBL] [Abstract][Full Text] [Related]
5. Functional and molecular determinants of right ventricular response to severe pulmonary hypertension in a large animal model.
Brown RD; Hunter KS; Li M; Frid MG; Harral J; Krafsur GM; Holt TN; Williams J; Zhang H; Riddle SR; Edwards MG; Kumar S; Hu CJ; Graham BB; Walker LA; Garry FB; Buttrick PM; Lahm T; Kheyfets VO; Hansen KC; Stenmark KR
Am J Physiol Heart Circ Physiol; 2023 Jun; 324(6):H804-H820. PubMed ID: 36961489
[TBL] [Abstract][Full Text] [Related]
6. Hypoxia-induced inhibition of mTORC1 activity in the developing lung: a possible mechanism for the developmental programming of pulmonary hypertension.
Mundo W; Wolfson G; Moore LG; Houck JA; Park D; Julian CG
Am J Physiol Heart Circ Physiol; 2021 Mar; 320(3):H980-H990. PubMed ID: 33416457
[TBL] [Abstract][Full Text] [Related]
7. Genetic ablation of interleukin-18 does not attenuate hypobaric hypoxia-induced right ventricular hypertrophy.
Bruns DR; Buttrick PM; Walker LA
Am J Physiol Lung Cell Mol Physiol; 2016 Mar; 310(6):L542-50. PubMed ID: 26747780
[TBL] [Abstract][Full Text] [Related]
8. Identification of Celastrol as a Novel Therapeutic Agent for Pulmonary Arterial Hypertension and Right Ventricular Failure Through Suppression of Bsg (Basigin)/CyPA (Cyclophilin A).
Kurosawa R; Satoh K; Nakata T; Shindo T; Kikuchi N; Satoh T; Siddique MAH; Omura J; Sunamura S; Nogi M; Takeuchi Y; Miyata S; Shimokawa H
Arterioscler Thromb Vasc Biol; 2021 Mar; 41(3):1205-1217. PubMed ID: 33472404
[TBL] [Abstract][Full Text] [Related]
9. Sulforaphane prevents right ventricular injury and reduces pulmonary vascular remodeling in pulmonary arterial hypertension.
Kang Y; Zhang G; Huang EC; Huang J; Cai J; Cai L; Wang S; Keller BB
Am J Physiol Heart Circ Physiol; 2020 Apr; 318(4):H853-H866. PubMed ID: 32108526
[TBL] [Abstract][Full Text] [Related]
10. Mitochondrial integrity in a neonatal bovine model of right ventricular dysfunction.
Bruns DR; Brown RD; Stenmark KR; Buttrick PM; Walker LA
Am J Physiol Lung Cell Mol Physiol; 2015 Jan; 308(2):L158-67. PubMed ID: 25416385
[TBL] [Abstract][Full Text] [Related]
11. Skeletal and cardiac muscle have different protein turnover responses in a model of right heart failure.
Bruns DR; McNair BD; Peelor FF; Borowik AK; Pranay A; Yusifov A; Miller BF
Geroscience; 2023 Aug; 45(4):2545-2557. PubMed ID: 37118350
[TBL] [Abstract][Full Text] [Related]
12. Pulmonary vascular mechanical consequences of ischemic heart failure and implications for right ventricular function.
Philip JL; Murphy TM; Schreier DA; Stevens S; Tabima DM; Albrecht M; Frump AL; Hacker TA; Lahm T; Chesler NC
Am J Physiol Heart Circ Physiol; 2019 May; 316(5):H1167-H1177. PubMed ID: 30767670
[TBL] [Abstract][Full Text] [Related]
13. Role of Hypoxia-Inducible Factors in Regulating Right Ventricular Function and Remodeling during Chronic Hypoxia-induced Pulmonary Hypertension.
Smith KA; Waypa GB; Dudley VJ; Budinger GRS; Abdala-Valencia H; Bartom E; Schumacker PT
Am J Respir Cell Mol Biol; 2020 Nov; 63(5):652-664. PubMed ID: 32692928
[TBL] [Abstract][Full Text] [Related]
14. Rapamycin attenuates hypoxia-induced pulmonary vascular remodeling and right ventricular hypertrophy in mice.
Paddenberg R; Stieger P; von Lilien AL; Faulhammer P; Goldenberg A; Tillmanns HH; Kummer W; Braun-Dullaeus RC
Respir Res; 2007 Feb; 8(1):15. PubMed ID: 17319968
[TBL] [Abstract][Full Text] [Related]
15. Eplerenone attenuates pathological pulmonary vascular rather than right ventricular remodeling in pulmonary arterial hypertension.
Boehm M; Arnold N; Braithwaite A; Pickworth J; Lu C; Novoyatleva T; Kiely DG; Grimminger F; Ghofrani HA; Weissmann N; Seeger W; Lawrie A; Schermuly RT; Kojonazarov B
BMC Pulm Med; 2018 Mar; 18(1):41. PubMed ID: 29499691
[TBL] [Abstract][Full Text] [Related]
16. The novel P2X7 receptor antagonist PKT100 improves cardiac function and survival in pulmonary hypertension by direct targeting of the right ventricle.
Hansen T; Karimi Galougahi K; Besnier M; Genetzakis E; Tsang M; Finemore M; O'Brien-Brown J; Di Bartolo BA; Kassiou M; Bubb KJ; Figtree GA
Am J Physiol Heart Circ Physiol; 2020 Jul; 319(1):H183-H191. PubMed ID: 32469637
[TBL] [Abstract][Full Text] [Related]
17. Contribution of Impaired Parasympathetic Activity to Right Ventricular Dysfunction and Pulmonary Vascular Remodeling in Pulmonary Arterial Hypertension.
da Silva Gonçalves Bós D; Van Der Bruggen CEE; Kurakula K; Sun XQ; Casali KR; Casali AG; Rol N; Szulcek R; Dos Remedios C; Guignabert C; Tu L; Dorfmüller P; Humbert M; Wijnker PJM; Kuster DWD; van der Velden J; Goumans MJ; Bogaard HJ; Vonk-Noordegraaf A; de Man FS; Handoko ML
Circulation; 2018 Feb; 137(9):910-924. PubMed ID: 29167228
[TBL] [Abstract][Full Text] [Related]
18. Selective Tuberous Sclerosis Complex 1 Gene Deletion in Smooth Muscle Activates Mammalian Target of Rapamycin Signaling and Induces Pulmonary Hypertension.
Houssaini A; Abid S; Derumeaux G; Wan F; Parpaleix A; Rideau D; Marcos E; Kebe K; Czibik G; Sawaki D; Treins C; Dubois-Randé JL; Li Z; Amsellem V; Lipskaia L; Pende M; Adnot S
Am J Respir Cell Mol Biol; 2016 Sep; 55(3):352-67. PubMed ID: 26991739
[TBL] [Abstract][Full Text] [Related]
19. Medical Therapy for Heart Failure Associated With Pulmonary Hypertension.
Zelt JGE; Chaudhary KR; Cadete VJ; Mielniczuk LM; Stewart DJ
Circ Res; 2019 May; 124(11):1551-1567. PubMed ID: 31120820
[TBL] [Abstract][Full Text] [Related]
20. Chronic hypoxia-induced alterations of the right ventricular myocardium are not aggravated by alimentary obesity in the mouse.
Mühlfeld C; Bienas LM; Bornemann M; Schipke J
Microvasc Res; 2024 Jan; 151():104618. PubMed ID: 37884172
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
